New drug trial hopes to slow kidney damage in rare alport syndrome
NCT ID NCT07523581
First seen Apr 17, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tests a drug called exaluren in 24 people aged 12 and older with Alport syndrome caused by specific genetic mistakes. The drug aims to improve kidney structure and reduce protein in urine. Participants first receive either exaluren or a placebo for 16 weeks, then everyone gets exaluren for another 16 weeks. The goal is to see if exaluren can help control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPORT SYNDROME, X-LINKED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alder Hey Children's NHS Foundation Trust
Liverpool, L12 2AP, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Denver Nephrologists PC, Colorado Kidney Care PC
Denver, Colorado, 80220, United States
-
Great Ormond Street Hospital
London, WC1N 3JH, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Free Hospital
London, NW3 2QG, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Manchester Children's Hospital
Manchester, M13 9WL, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.